Combination chemotherapy with p53 gene therapy
This page covers all Combination chemotherapy with p53 gene therapy drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting p53 tumor suppressor protein.
Targets
Marketed (1)
- chemotherapy plus p53 · Shenzhen SiBiono GeneTech Co.,Ltd · Oncology
This combination therapy uses chemotherapy alongside a p53 gene therapy to restore tumor suppressor function and enhance cancer cell death.
Patent intelligence
- combination chemotherapy with p53 gene therapy patent landscape — aggregated cliff calendar, attackable patents, originator estates